Table 2.
Summative demographic data and clinical features of patients of LDLT who underwent RYHJ
| Median (range) | ||
|---|---|---|
| Recipient age (years) | 50.5 (39–71) | |
| MELD score | 13 (6–28) | |
| Cold ischemia time (min) | 84.5 (23–155) | |
| Warm ischemia time (min) | 18 (1–38) | |
| Anhepatic phase time(min) | 28 (15–100) | |
| Transplantation operative time (min) | 360 (180–540) | |
| Transplantation blood loss (ml) | 2650 (600–8000) | |
| Hepaticojejunostomy operative time (min) | 260 (180–530) | |
| Hepaticojejunostomy blood loss (ml) | 300 (100–7000) | |
| Time from RL-LDLT to RYHJ (month) | 23.5 (0–58) | |
| No. | (%) | |
| Gender | ||
| Male | 18 | 81.8 |
| Female | 4 | 18.2 |
| Bile leak | ||
| Yes | 12 | 54.5 |
| No | 10 | 45.5 |
| No. of bile duct orifice | ||
| 1 | 14 | 63.6 |
| 2 | 7 | 31.8 |
| 3 | 1 | 4.5 |
| Type of bile duct anastomosis | ||
| D-G | 12 | 54.5 |
| D-D | 10 | 45.5 |
| T-tube placement | ||
| Yes | 5 | 22.7 |
| No | 17 | 77.3 |
| Hepatic artery complications | ||
| Yes | 3 | 13.6 |
| No | 19 | 86.4 |
| IHD stone | ||
| Yes | 14 | 63.6 |
| No | 8 | 36.4 |
| ABO incompatibility | ||
| Yes | 4 | 18.2 |
| No | 18 | 81.8 |
| Rejection | ||
| Yes | 8 | 36.4 |
| No | 14 | 63.6 |
| Survival | ||
| Alive | 14 | 63.6 |
| Death | 8 | 36.4 |
LDLT Living donor liver transplantation, RYHJ Roux-en-Y hepaticojejunostomy, SD Standard deviation, MELD Model for End-Stage Liver Disease, D-G Duct-to-Glissonean sheath anastomosis, D-D Duct-to-duct anastomosis, IHD Intrahepatic duct